NO20022739L - Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser - Google Patents

Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser Download PDF

Info

Publication number
NO20022739L
NO20022739L NO20022739A NO20022739A NO20022739L NO 20022739 L NO20022739 L NO 20022739L NO 20022739 A NO20022739 A NO 20022739A NO 20022739 A NO20022739 A NO 20022739A NO 20022739 L NO20022739 L NO 20022739L
Authority
NO
Norway
Prior art keywords
prevention
dioxino
neuroleptics
benzylamino
indol
Prior art date
Application number
NO20022739A
Other languages
English (en)
Other versions
NO20022739D0 (no
Inventor
Karen Lovell Marquis
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20022739D0 publication Critical patent/NO20022739D0/no
Publication of NO20022739L publication Critical patent/NO20022739L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

Terapeutiske kombinasjoner nyttige for behandling eller forhindring av psykotiske lidelser, farmasøytiske preparater inneholdende nevnte kombinasjoner og anvendelse av dem for behandling eller forhindring av psykotiske lidelser er tilveiebragt.
NO20022739A 1999-12-10 2002-06-07 Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser NO20022739L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45860799A 1999-12-10 1999-12-10
PCT/US2000/033060 WO2001041750A2 (en) 1999-12-10 2000-12-07 Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics

Publications (2)

Publication Number Publication Date
NO20022739D0 NO20022739D0 (no) 2002-06-07
NO20022739L true NO20022739L (no) 2002-06-07

Family

ID=23821437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022739A NO20022739L (no) 1999-12-10 2002-06-07 Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser

Country Status (20)

Country Link
EP (1) EP1235570A2 (no)
JP (1) JP5557409B2 (no)
KR (1) KR100772854B1 (no)
CN (1) CN1230164C (no)
AR (1) AR026756A1 (no)
AU (1) AU784211B2 (no)
BR (1) BR0016168A (no)
CA (1) CA2396351C (no)
CZ (1) CZ20021880A3 (no)
EA (1) EA005002B1 (no)
HK (1) HK1045942A1 (no)
HU (1) HUP0203309A3 (no)
IL (2) IL149669A0 (no)
MX (1) MXPA02005649A (no)
NO (1) NO20022739L (no)
NZ (1) NZ519381A (no)
PL (1) PL355292A1 (no)
TW (1) TWI222864B (no)
WO (1) WO2001041750A2 (no)
ZA (1) ZA200205484B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050095292A1 (en) 2003-10-29 2005-05-05 Wyeth Sustained release pharmaceutical compositions
CA2597616A1 (en) 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
DK2254598T3 (da) * 2008-02-13 2013-07-29 Targacept Inc Kombination af alfa 7-nikotinagonister og antipsykotika

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2987484B2 (ja) * 1995-03-16 1999-12-06 大塚製薬 株式会社 カルボスチリル誘導体の製造方法
US5756532A (en) * 1995-11-06 1998-05-26 American Home Products Corporation Aminomethyl-2 3 8 9-tetrahydro-7H-1 4-dioxino 2 3-E!-indol-8-ones and derivatives
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents

Also Published As

Publication number Publication date
AU1949001A (en) 2001-06-18
WO2001041750A2 (en) 2001-06-14
NZ519381A (en) 2004-04-30
TWI222864B (en) 2004-11-01
AU784211B2 (en) 2006-02-23
CA2396351C (en) 2009-11-10
CN1409633A (zh) 2003-04-09
KR20030016207A (ko) 2003-02-26
AR026756A1 (es) 2003-02-26
HUP0203309A2 (hu) 2003-01-28
CA2396351A1 (en) 2001-06-14
IL149669A0 (en) 2002-11-10
CZ20021880A3 (cs) 2002-08-14
EA200200656A1 (ru) 2002-12-26
MXPA02005649A (es) 2004-09-10
EA005002B1 (ru) 2004-10-28
BR0016168A (pt) 2002-08-20
NO20022739D0 (no) 2002-06-07
PL355292A1 (en) 2004-04-05
HUP0203309A3 (en) 2004-12-28
HK1045942A1 (zh) 2002-12-20
IL149669A (en) 2006-06-11
JP5557409B2 (ja) 2014-07-23
EP1235570A2 (en) 2002-09-04
CN1230164C (zh) 2005-12-07
JP2003516350A (ja) 2003-05-13
KR100772854B1 (ko) 2007-11-02
WO2001041750A3 (en) 2002-02-14
ZA200205484B (en) 2003-12-31

Similar Documents

Publication Publication Date Title
NO996433D0 (no) Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
HUP9901807A3 (en) Heterocycle substituted n-acyl benzenesulfonamide derivatives, process for their preparation and their use as prodrug for the preparation of pharmaceutical compositions treating inflammation or inflammation-associated disorders
HUP9601566A2 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
IT1271462B (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
NO963568D0 (no) Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
CA2294921A1 (en) Levobupivacaine and its use
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
NO307510B1 (no) Bicykliske aromatiske forbindelser, deres anvendelse og farmasøytiske og kosmetiske preparater derav
EE03663B1 (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
EP1440691A3 (en) Treatment of neurotic disorders
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
NO307930B1 (no) Benzo[f]kinolinoner, farmasøytisk formulering omfattende samme og anvendelse av samme for fremstilling av formulering for behandling
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
AR013264A1 (es) Derivados de 4-oxo-3,5-dihidro-4h-piridazino[4,5-b]indol-1-acetamida, medicamento y composicinn farmaceutica
NO20022739L (no) Nye terapeutiske kombinasjoner av (S)-2-(benzylamino-metyl)-2,3,8,9-tetrahydro-7H-1,4-dioksino[2,3-e]indol-8-on og nevroleptika for behandling eller forhindring av psykotiske lidelser
WO1999020291A3 (en) Pharmaceutical grade ginkgo biloba
FR2765582B1 (fr) Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
AU2001235706A1 (en) Cosmetic or medicinal composition containing sesquiterpene lactone or the like for treating hair-growth related disorders, and preparation method
WO2000063348A3 (fr) Composition pharmaceutique comprenant des cellules nkt activees par des pim, et son utilisation en therapie
IL127690A0 (en) Pyridinocyclohexano-1,3- pyrimidine derivatives their preparation their use as medicaments and pharmaceutical formulations including them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application